Version 2.77

Part Descriptions

LP18483-5   Oxipurinol
Oxypurinol is an inhibitor of xanthine oxidase. It is an active metabolite of allopurinol and it is cleared renally. In cases of renal disease, this metabolite will accumulate to toxic levels. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Oxypurinol

LP18483-5   Oxipurinol
Oxipurinol [alloxanthine, Oxyprim, oxypurinol] is the active metabolite of the only commercially available xanthine oxidase inhibitor, allopurinol. Oxipurinol is also a xanthine oxidase inhibitor. Oxipurinol is currently being developed by Cardiome Pharma. It is waiting for approval in the US for the treatment of allopurinol-intolerant hyperuricaemia (gout) and is in phase III trials for the treatment of congestive heart failure. Allopurinol is indicated for the treatment of symptomatic hyperuricaemia, or gout. Approximately 3-5% of patients receiving allopurinol develop intolerance to the drug. Oxipurinol was originally developed by Burroughs Wellcome (later GlaxoSmithKline), and has been available on a compassionate-use basis since 1967 for use in allopurinol-intolerant patients. The licensee company ILEX Oncology has stated that oxipurinol does not have patent protection. Oxipurinol's potential for treatment of congestive heart failure is based on the possibility that xanthine oxidase inhibitors may improve myocardial work efficiency by sensitising cardiac muscle cells to calcium ions, which are a key determinant of cardiac muscle function. This results in more efficient contraction of cardiac muscle cells, without the same increase in oxygen demand. At the second annual BioPartnering North America conference (BPN-2004) [February 2004, Vancouver, Canada], Cardiome Pharma stated that it was seeking a commercialisation partner to market and distribute oxipurinol in the US for the treatment of allopurinol-intolerant hyperuricaemia. [Drugs R D. 2004;5(3):171-5.] Source: NCBI PubMed, PMID:15139781

Fully-Specified Name

Component
Oxipurinol
Property
MCnc
Time
Pt
System
Bld
Scale
Qn
Method

Additional Names

Short Name
Oxipurinol Bld-mCnc
Display Name
Oxipurinol (Bld) [Mass/Vol]
Consumer Name Alpha Get Info
Oxipurinol, Blood

Basic Attributes

Class
DRUG/TOX
Type
Laboratory
First Released
Version 2.34
Last Updated
Version 2.70
Order vs. Observation
Both

Member of these Groups Get Info

LOINC Group Group Name
LG1986-1 Oxipurinol|MCnc|Pt|ANYBldSerPl

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Oxipurinol:Concentración de masa:Punto temporal:Sangre:Cuantitativo:
es-ES Spanish (Spain) Oxipurinol:Concentración de masa:Punto temporal:Sangre:Qn:
Synonyms: Cuantitativo
et-EE Estonian (Estonia) Oksipurinool:MCnc:Pt:B:Qn:
Synonyms: Juhuslik Kvantitatiivne Veri
fr-CA French (Canada) Oxipurinol:Concentration de masse:Temps ponctuel:Sang:Quantitatif:
fr-FR French (France) Oxipurinol:Masse/Volume:Ponctuel:Sang:Numérique:
fr-BE French (Belgium) Oxipurinol:Concentration de masse:Temps ponctuel:Sang:Quantitatif:
it-IT Italian (Italy) Ossipurinolo:MCnc:Pt:Sangue:Qn:
Synonyms: Concentrazione di Massa Livelli farmacologici e tossicologia Punto nel tempo (episodio) Sangue
nl-NL Dutch (Netherlands) oxipurinol:massa/volume:moment:bloed:kwantitatief:
pt-BR Portuguese (Brazil) Oxipurinol::Pt:SgTotal:Qn:
ru-RU Russian (Russian Federation) Оксипуринол:МассКонц:ТчкВрм:Кр:Колич:
Synonyms: Количественный Кровь Массовая концентрация Точка во времени;Момент
tr-TR Turkish (Turkey) Oksipürinol:KütlKons:Zmlı:Kan:Kant:
zh-CN Chinese (China) 奥昔嘌醇:质量浓度:时间点:全血:定量型:
Synonyms: 别嘌二醇;别嘌呤醇代谢产物 可用数量表示的;定量性;数值型;数量型;连续数值型标尺 时刻;随机;随意;瞬间 毒品 毒品类 水平;浓度;质量浓度(单位体积) 药品类 药物 药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类 药物类 血;血液

Example Units

Unit Source
ug/mL Example UCUM Units

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=60112-0